Go Pro
→ Nvidia's CEO says this small device is critical for AI growth (From Brownstone Research) (Ad)tc pixel Free INTS Stock Alerts

Intensity Therapeutics (INTS) Earnings Date, Estimates & Call Transcripts

Intensity Therapeutics logo
$4.15 +0.19 (+4.80%)
Closing price 08/17/2026 04:00 PM Eastern
Extended Trading
$4.13 -0.02 (-0.51%)
As of 07:30 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare

Intensity Therapeutics Earnings Summary

Intensity Therapeutics announced Q2 2026 earnings on August 11, 2026, reporting an EPS of -$1.11, which missed analysts' consensus estimates of -$0.87 by $0.24. With a trailing EPS of -$5.71, Intensity Therapeutics' earnings are expected to grow next year, from ($2.70) to ($1.90) per share.

Upcoming Q3
Earnings Date
Nov. 5Before Market OpensEstimated
Consensus EPS
(Aug. 11)
-$0.87
Actual EPS
(Aug. 11)
-$1.11 Missed By -$0.24

Q2 2026 Earnings Resources

INTS Upcoming Earnings

Intensity Therapeutics' next earnings date is estimated for Thursday, November 5, 2026, based on past reporting schedules.

Powered by Quartr
Get Intensity Therapeutics Earnings Alerts

Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Intensity Therapeutics and other key companies, straight to your inbox.

Sign Up
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Estimated and Actual Earnings Data

INTS Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Intensity Therapeutics Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20262-$1.50-$1.19-$1.35
Q2 20262-$1.50-$0.81-$1.16
Q3 20262-$1.50-$0.77-$1.14
Q4 20262-$1.50-$0.71-$1.11

Intensity Therapeutics Earnings History by Quarter

Export
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueDetails
11/5/2026
(Estimated)		--------
8/11/2026Q2 2026-$0.8725-$1.11 -$0.2375-$1.11--
5/7/2026Q1 2026-$1.0850-$0.96+$0.1250-$0.96--
3/27/2026Q4 2025--$0.31--$0.31--
11/6/2025Q3 2025-$1.50-$1.50--$0.06--
8/7/2025Q2 2025--$3.25--$0.13--
5/13/2025Q1 2025-$5.25-$5.50 -$0.25-$0.22--
3/13/2025Q4 2024-$5.75-$5.50+$0.25-$0.22--

Intensity Therapeutics Earnings - Frequently Asked Questions

Intensity Therapeutics has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 5th, 2026 based off last year's report dates. Learn more on INTS's earnings history.

In the previous quarter, Intensity Therapeutics (NASDAQ:INTS) missed the analysts' consensus estimate of ($0.87) by $0.24 with a reported earnings per share (EPS) of ($1.11). Learn more on analysts' earnings estimate vs. INTS's actual earnings.

The conference call for Intensity Therapeutics' latest earnings report can be listened to online.
Listen to Conference Call

The conference call transcript for Intensity Therapeutics' latest earnings report can be read online.
Read Transcript

Intensity Therapeutics' earnings report can be found in their filing with the SEC.
View SEC filing

Intensity Therapeutics (NASDAQ:INTS) has a recorded net income of -$11.61 million. INTS has generated -$5.71 earnings per share over the last four quarters.

Intensity Therapeutics' earnings are expected to grow from ($2.70) per share to ($1.90) per share in the next year.

Related Companies
Earnings Tools

Earnings data for NASDAQ:INTS is sourced from Fiscal.ai, with the most recent quarter reported on 8/11/2026. New results are added as companies report their earnings.
From Our Partners
Elon's Terrifying Warning: America Is "1,000% Going Bankrupt"
The national debt just crossed $39 trillion, and Elon Musk - former head of the Department of Government Effic...
American Hartford Gold | Sponsoredtc pixel
Three oil giants buried the same discovery for 50 years
In 1976, Chevron tapped an energy source with no fuel costs, no carbon, and no supply chain - then killed the ...
Behind the Markets | Sponsoredtc pixel
Iran War: What Happened at 1:11 P.M. Outside D.C.?
A source with ties to Saudi Arabia, the UAE, and the U.S. State Department revealed details of a potential 7 t...
Banyan Hill Publishing | Sponsoredtc pixel
Trump’s New Currency Reset
Trump is launching a new $250 bill - but that may be a distraction. Behind the scenes, Executive Order 14241 i...
Porter & Company | Sponsoredtc pixel
19 Factories. One AI Brain. One Hidden Stock.
A little-known aerospace manufacturer has linked 19 factories worldwide into a single AI-ready data system, dr...
The Oxford Club | Sponsoredtc pixel
A Dark Day Is Coming to America
Keith Kaplan, CEO of TradeSmith, has spent more than $17 million studying AI since 2022. He says a major shift...
TradeSmith | Sponsoredtc pixel
Here’s the stock symbol I’ve promised
Whitney Tilson of Stansberry Research has long recommended Berkshire Hathaway as a core retirement holding - b...
Stansberry Research | Sponsoredtc pixel
Your withdrawal order could cost you in taxes
If you have $2M or more saved, the 4% rule points to roughly $92,000 a year - but it's a single-variable answe...
SmartAsset | Sponsoredtc pixel